Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,312 | -14,927 | -27,582 | -6,523 | -18,276 |
| Depreciation Amortization | 1,458 | 1,386 | 3,791 | 4,772 | 4,608 |
| Income taxes - deferred | -3,092 | N/A | N/A | N/A | N/A |
| Accounts receivable | -428 | -1,194 | -1,032 | 2,091 | 188 |
| Other Working Capital | -10,589 | -12,012 | 9,801 | -27,158 | -6,893 |
| Other Operating Activity | 3,021 | 1,747 | 4,737 | 712 | 1,015 |
| Operating Cash Flow | $-1,318 | $-25,000 | $-10,285 | $-26,106 | $-19,358 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | 11,000 | 58,271 | 384 | -259 |
| PPE Investments | -1,149 | -628 | -1,406 | -655 | -627 |
| Purchase Of Investment | -20,420 | -16,000 | -37,835 | -20,000 | N/A |
| Other Investing Activity | -142 | 593 | -109 | 319 | 3 |
| Investing Cash Flow | $-16,711 | $-5,035 | $18,921 | $-19,952 | $-883 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -34,122 | -215 | N/A |
| Common Stock Issued | 24,666 | 8,238 | 46,200 | 46,682 | N/A |
| Financing Cash Flow | $24,666 | $8,238 | $12,078 | $46,467 | $N/A |
| Exchange Rate Effect | -114 | -77 | 6 | 64 | 225 |
| Beginning Cash Position | 17,111 | 38,985 | 18,265 | 17,792 | 37,808 |
| End Cash Position | 23,634 | 17,111 | 38,985 | 18,265 | 17,792 |
| Net Cash Flow | $6,523 | $-21,874 | $20,720 | $473 | $-20,016 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,318 | -25,000 | -10,285 | -26,106 | -19,358 |
| Capital Expenditure | -1,149 | -628 | -1,459 | -655 | -627 |
| Free Cash Flow | -2,467 | -25,628 | -11,744 | -26,761 | -19,985 |